SANTA CLARA, Calif., Oct.

RALEIGH and DURHAM, N.C., Aug. 19 /PRNewswire-FirstCall/ -- Smith & Nephew (NYSE: SNN; LSE: SN) Biologics & Spine is proceeding to the next stage in the approval process for the U.S.

Biologics, an oncology management company, has announced that a new oral drug for the treatment of relapsed small cell lung cancer, Hycamtin capsules, is now available through its oncology pharmacy.